Ruan Ping, Yan Jie, Mao Ya-fei, Peng Hui-qin, Zhou Xiao-hui
Department of Medical Microbiology and Parasitology, Medical School of Shaoxing University, Shaoxing 312000, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Aug;26(8):608-12.
To construct prokaryotic expression systems of ltB/ctB-lipL41/1 fusion genes, identify immunogenic and adjuvant activities of the products as well as to understand the frequencies of lipL41 gene that carrying and expressing in L. interrogans wild strains and specific antibody levels in sera from patients with leptospirosis.
Polymerase chain reaction (PCR) with linking primer was applied to construct the fusion genes ltB-lipL41/1 and ctB-lipL41/1. By routine molecular biological techniques, prokaryotic expression systems of the two fusion genes were constructed. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to examine expression of the target recombinant proteins rLTB-rLipL41/1 and rCTB-rLipL41/1. Both western blot and Ganglioside-enzyme linked immunosorbent assay (GM-ELISA) were used while immunogenic and adjuvant activities of rLTB-rLipL41/1 and rCTB-rLipL41/1 were measured. PCR and MAT were performed to detect lipL41 gene and expression of the gene in 97 wild strains of L. interrogans, respectively. Antibodies against product of lipL41 gene in serum samples from 228 leptospirosis patients were detected by ELISA.
In comparison with reported corresponding sequences, the similarities of ltB-lipL41/1 and ctB-lipL41/1 fusion genes to nucleotide and putative amino acid sequence were 99.6%-99.9% and 99.8%-100%, respectively. Expression outputs of both rLTB-rLipL41/1 and rCTB-rLipL41/1, mainly presenting with inclusion body, consisting approximate 10% of the total bacterial proteins. Both rLTB-rLipL41/1 and rCTB-rLipL41/1 could combine rabbit anti-rLipL41/1 serum as well as bovine GM1, respectively. 87.6% of the L. interrogans wild strains(85/97) having lipL41 gene while 84.5% (82/97) of the wild strains with rLipL41/1 or rLipL41/2 antiserum were positive for MAT with titers of 1:4-1:128. 84.6% (193/ 228), 78.5% (179/228) from the patients' serum samples were positive for rLipL41/1 and rLipL41/2 antibodies, respectively.
ltB-lipL41/1 and ctB-lipL41/1 fusion genes and their prokaryotic expression systems were successfully constructed in this study. The two expressed fusion proteins showed qualified immunogenic and adjuvant activities. lipL41 gene was extensively distributed and frequently expressed in different serogroups of L. interrogans. rLTB-rLipL41/1 or rCTB-rLipL41/1 seemed to have had good potential to serve as an antigen in L. interrogans genus-specific vaccine.
构建ltB/ctB-lipL41/1融合基因的原核表达系统,鉴定产物的免疫原性和佐剂活性,了解问号钩端螺旋体野生株中lipL41基因携带和表达情况以及钩端螺旋体病患者血清中特异性抗体水平。
采用连接引物的聚合酶链反应(PCR)构建融合基因ltB-lipL41/1和ctB-lipL41/1。通过常规分子生物学技术构建这两个融合基因的原核表达系统。用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)检测目标重组蛋白rLTB-rLipL41/1和rCTB-rLipL41/1的表达。采用蛋白质印迹法和神经节苷脂-酶联免疫吸附测定(GM-ELISA)检测rLTB-rLipL41/1和rCTB-rLipL41/1的免疫原性和佐剂活性。分别采用PCR和显微镜凝集试验(MAT)检测97株问号钩端螺旋体野生株中lipL41基因及其表达情况。用ELISA检测228例钩端螺旋体病患者血清样本中针对lipL41基因产物的抗体。
与已报道的相应序列相比,ltB-lipL41/1和ctB-lipL41/1融合基因与核苷酸及推测氨基酸序列的相似性分别为99.6%-99.9%和99.8%-100%。rLTB-rLipL41/1和rCTB-rLipL41/1的表达产物主要以包涵体形式存在,约占细菌总蛋白的10%。rLTB-rLipL41/1和rCTB-rLipL41/1分别能与兔抗rLipL41/1血清以及牛GM1结合。87.6%(85/97)的问号钩端螺旋体野生株携带lipL41基因,84.5%(82/97)的野生株用rLipL41/1或rLipL41/2抗血清进行MAT检测呈阳性,滴度为1:4-1:128。患者血清样本中84.6%(193/228)、78.5%(179/228)分别对rLipL41/1和rLipL41/2抗体呈阳性。
本研究成功构建了ltB-lipL41/1和ctB-lipL41/1融合基因及其原核表达系统。两种表达的融合蛋白具有良好的免疫原性和佐剂活性。lipL41基因在问号钩端螺旋体不同血清群中广泛分布且频繁表达。rLTB-rLipL41/1或rCTB-rLipL41/1似乎有潜力作为问号钩端螺旋体属特异性疫苗的抗原。